Form 5500 · Employee benefit plan · SCOTTSDALE, AZ
TRANSLATIONAL DRUG DEVELOPMENT
Public Form 5500 records show how TRANSLATIONAL DRUG DEVELOPMENT (SCOTTSDALE, AZ) structures its employee benefits. Its broker of record is AMALYN CONSULTING, LLC. Coverage is written through CIGNA HEALTH AND LIFE INSURANCE COMPANY and 1 other carrier. The plan's most recent policy period ended in March.
Sourced from U.S. DOL EFAST2 Form 5500 · EIN 46-4150915 · plan 502 · as of Jul 2026
Schedule A insurance contracts
| Carrier | Benefits | Covered | Renews | Commission |
|---|---|---|---|---|
| CIGNA HEALTH AND LIFE INSURANCE COMPANY | Health | 163 | March | $83,742 |
| PRINCIPAL LIFE INSURANCE COMPANY | Dental, Vision, Life, Disability | 269 | March | $36,039 |
Questions
Who is TRANSLATIONAL DRUG DEVELOPMENT's benefits broker?
Per its most recent Form 5500 Schedule A, TRANSLATIONAL DRUG DEVELOPMENT's broker of record is AMALYN CONSULTING, LLC.
What insurance carrier does TRANSLATIONAL DRUG DEVELOPMENT use?
TRANSLATIONAL DRUG DEVELOPMENT's benefit plan is written through CIGNA HEALTH AND LIFE INSURANCE COMPANY, among 2 disclosed carriers.
When does TRANSLATIONAL DRUG DEVELOPMENT's group plan renew?
The most recent Schedule A policy period for TRANSLATIONAL DRUG DEVELOPMENT ended in March. Group plans typically renew on the same annual cycle.
Where does this data come from?
All figures are drawn from TRANSLATIONAL DRUG DEVELOPMENT's public Form 5500 filing with the U.S. Department of Labor (EFAST2). Form 5500 is a public record.